What are the causes of a slightly elevated calprotectin (fecal calprotectin) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Slightly Elevated Calprotectin

Slightly elevated fecal calprotectin (50-250 μg/g) is most commonly caused by NSAID use, colorectal neoplasia, infectious gastroenteritis, and untreated celiac disease, in addition to early or mild inflammatory bowel disease. 1, 2

Primary Non-IBD Causes to Consider

Medication-Related Causes

  • NSAID use within the past 6 weeks is one of the most common causes of false elevation, including over-the-counter ibuprofen, naproxen, and aspirin at anti-inflammatory doses through direct mucosal injury. 2, 3
  • Proton pump inhibitor (PPI) use is significantly associated with elevated calprotectin, with users having nearly 4-fold increased odds of elevated levels (adjusted OR: 3.843) compared to non-users. 3
  • Acetylsalicylic acid use increases the odds of elevated calprotectin nearly 3-fold (adjusted OR: 2.934). 3

Structural and Neoplastic Causes

  • Colorectal cancer and advanced adenomas elevate calprotectin and must be excluded, particularly in patients over age 50 or those with alarm symptoms like rectal bleeding. 1, 2, 4
  • Hemorrhoids can cause false elevations due to local bleeding and inflammation, particularly when visible rectal bleeding is present. 2

Infectious and Inflammatory Causes

  • Infectious gastroenteritis significantly elevates calprotectin during active infection and may remain mildly elevated during recovery. 1, 4, 5
  • Untreated celiac disease causes intestinal inflammation that elevates calprotectin levels. 2

Physiologic Factors

  • Age is independently associated with elevated calprotectin, with each year of age increasing odds by approximately 5% (adjusted OR: 1.051 per year). 3

Clinical Significance of Slightly Elevated Levels

The Indeterminate Range (50-250 μg/g)

  • Values between 50-250 μg/g represent an indeterminate range with an 8% chance of developing IBD over 12 months, compared to only 1% in those with levels <50 μg/g. 1
  • The British Society of Gastroenterology notes that this indeterminate range remains clinically challenging to interpret, as mild elevation may reflect non-specific low-grade inflammation. 1

Specificity Improves at Higher Thresholds

  • Values >100 μg/g provide 78.2% specificity for endoscopically active disease. 6, 2
  • Values >250 μg/g strongly suggest active inflammation with 82% specificity, correlating well with endoscopic inflammation. 1, 2

Diagnostic Approach to Slightly Elevated Calprotectin

Initial Assessment Steps

  • Review all medications taken in the past 6 weeks, particularly NSAIDs, PPIs, and aspirin, and discontinue if clinically appropriate. 2, 3
  • Ensure celiac serology (tissue transglutaminase antibodies) has been checked, as this is recommended by the British Society of Gastroenterology for all patients with chronic diarrhea. 1, 2
  • Assess for recent infectious gastroenteritis, as calprotectin may remain elevated during recovery. 4, 5

When to Proceed to Colonoscopy

  • Patients with alarm symptoms (rectal bleeding, abdominal pain) require cancer pathway referral regardless of calprotectin result, as calprotectin is not sensitive enough to exclude colorectal cancer. 7
  • Values >250 μg/g strongly indicate need for urgent endoscopic assessment to evaluate for active inflammatory disease. 1, 7, 2
  • For values 100-250 μg/g, consider routine gastroenterology referral with colonoscopy and biopsies to evaluate for microscopic colitis, colorectal neoplasia, and other mucosal abnormalities. 2

Alternative Strategy for Lower Elevations

  • Repeat testing in 4-6 weeks may be reasonable before proceeding to colonoscopy if the value is in the 50-250 μg/g range and the patient has recently stopped NSAIDs or recovered from suspected infection. 2

Important Clinical Caveats

False Positive Considerations

  • In asymptomatic patients with elevated calprotectin >150 μg/g, the false positive rate is 22.4%, meaning nearly one-quarter may not have significant endoscopic inflammation. 7, 2
  • Calprotectin is highly sensitive (90.6%) but has lower specificity for IBD due to multiple other conditions that elevate this marker. 6, 2, 8

Sample Collection Best Practices

  • Use the first stool passed in the morning and ensure analysis within 3 days at room temperature to avoid falsely elevated or degraded results. 6, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Elevated Calprotectin Levels: Causes and Next Steps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Research

Faecal Calprotectin.

The Clinical biochemist. Reviews, 2018

Guideline

Calprotectin as a Biomarker for Intestinal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fecal Calprotectin Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fecal calprotectin as an index of intestinal inflammation.

Drugs of today (Barcelona, Spain : 1998), 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.